What Should Clinicians Do to Engage the Public About Gene Editing
Datos Bibliográficos
| ID | 15745277 |
|---|---|
| Autores | Tom Alsaigh (0000-0001-8181-584X, Scripps Research Institute, autor de correspondencia), Laura Nicholson (0000-0002-1761-0951, Scripps Research Institute), Eric J Topol (0000-0002-1478-4729, Scripps Research Institute) |
| Año | 2019 |
| Volumen | 21 |
| Número | 12 |
| Páginas | E1089-1097 |
| Fecha de publicación | 2019-12-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | The AMA Journal of Ethic (JOURNAL) |
| Identificadores de la revista | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Editorial | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2019.1089 |
| PMID | 31876474 |
| OpenAlex | W2990673579 |
| Idioma | EN |
| Referencias citadas | 1 |
Genome editing holds tremendous promise for preventing, ameliorating, or even curing disease, but a thorough discussion of its bioethical and social implications is necessary to protect humankind against harm, a central tenet of the original Hippocratic Oath. It is therefore essential that medical students, physicians, and all health care workers have a working understanding of what gene editing entails, the controversy surrounding its use, and its far-reaching clinical and ethical implications
Bioethics · Biology · CRISPR · Engineering ethics · Gene · Genome editing · Harm · Health care · Hippocratic Oath · Political science · Psychiatry · CRISPR and Genetic Engineering · Engineering · Innovation and Socioeconomic Development · Law · Medicine · Neuroethics, Human Enhancement, Biomedical Innovations · Genetics
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |